Latest Safety News

Novo Resources reported a reduced net loss of CAD 1.625 million in Q1 2025, progressing exploration with a new aircore drilling program in Western Australia while facing liquidity challenges that cast doubt on its near-term financial sustainability.

First Graphene has secured a multi-year exclusive deal to supply graphene-enhanced masterbatch for safety boots aimed at Southeast Asia’s mining sector, marking a significant step in commercialising advanced materials in industrial apparel.

Larvotto Resources has released a definitive feasibility study for its Hillgrove Antimony-Gold Project, confirming robust economics and a targeted production start in 2026. The study outlines an 8-year mine life with strong margins and advanced project financing talks.

HyTerra Limited has confirmed hydrogen concentrations up to 96.1% in its Sue Duroche 3 well in Kansas, reinforcing the potential of its natural hydrogen exploration program. Elevated helium levels were also detected, with further testing planned to assess commercial viability.

Cardiex Limited has formally lodged its CONNEQT Pulse device with Australia's Therapeutics Goods Administration, marking a critical step toward regulatory approval and market expansion.

Global Uranium and Enrichment Limited has completed a scoping study for its Hansen Deposit in Colorado, revealing strong economic potential through innovative mining and beneficiation methods.

Silex Systems reports steady progress on its TRL-6 uranium enrichment demonstration, targeting completion by end-2025, while securing initial US government funding to support commercialisation efforts.

Dimerix has received a US$30 million upfront payment from Amicus Therapeutics for exclusive US rights to DMX-200, a promising kidney disease therapy. The deal positions Dimerix for up to US$560 million in further milestones plus royalties, underpinning its global licensing strategy.

Lefroy Exploration has kicked off a major grade control drilling campaign at its Lucky Strike Gold Project, fully funded by partner BML Ventures, aiming to underpin mining operations slated for the second half of 2025.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Critica Limited has secured drilling approvals and government funding to explore high-grade heavy rare earth elements at its Aurora and Juno satellite prospects near the flagship Jupiter deposit in Western Australia.

Neurotech International has reported excellent safety and tolerability for its lead drug NTI164 in 28-day GLP toxicology studies, paving the way for regulatory submissions and longer-term clinical development.